These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32669304)

  • 1. Response to: 'Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India' by Goyal
    Mathian A; Amoura Z
    Ann Rheum Dis; 2021 May; 80(5):e72. PubMed ID: 32669304
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India.
    Goyal M; Patil P; Pathak H; Santhanam S; Goel A; Sharma V; Pandey A; Gupta N; Jain R; Akerkar S; Das P; Dudam R; Mendiratta N; Pandey BD; Cb M; Singh BK; Kumar S; Nolkha N; Jain S; Jain S; Sharma A; Misra DP
    Ann Rheum Dis; 2021 May; 80(5):e71. PubMed ID: 32669305
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients.
    Ramirez GA; Gerosa M; Beretta L; Bellocchi C; Argolini LM; Moroni L; Della Torre E; Artusi C; Nicolosi S; Caporali R; Bozzolo EP; Dagna L;
    Semin Arthritis Rheum; 2020 Oct; 50(5):1150-1157. PubMed ID: 32927376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.
    Monti S; Montecucco C
    Ann Rheum Dis; 2020 Jun; 79(6):e62. PubMed ID: 32327429
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Romão
    Joob B; Wiwanitkit V
    Ann Rheum Dis; 2021 Feb; 80(2):e24. PubMed ID: 32404341
    [No Abstract]   [Full Text] [Related]  

  • 6. SLE patients are not immune to covid-19: importance of sending the right message across.
    Goyal M
    Ann Rheum Dis; 2021 Feb; 80(2):e23. PubMed ID: 32327426
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to 'Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic' by Chuah
    Mathian A; Amoura Z
    Ann Rheum Dis; 2022 Aug; 81(8):e145. PubMed ID: 32883652
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
    Peschken CA
    J Rheumatol; 2020 Jun; 47(6):787-790. PubMed ID: 32269064
    [No Abstract]   [Full Text] [Related]  

  • 9. SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment.
    Joob B; Wiwanitkit V
    Ann Rheum Dis; 2020 Jun; 79(6):e61. PubMed ID: 32295787
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxychloroquine shortages during the COVID-19 pandemic.
    Mendel A; Bernatsky S; Thorne JC; Lacaille D; Johnson SR; Vinet É
    Ann Rheum Dis; 2021 Mar; 80(3):e31. PubMed ID: 32434820
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 in patients with systemic lupus erythematosus: A systematic review.
    Fu XL; Qian Y; Jin XH; Yu HR; Du L; Wu H; Chen HL; Shi YQ
    Lupus; 2022 May; 31(6):684-696. PubMed ID: 35382637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: comment by Joob and Wiwanitkit.
    Romão VC; Cruz-Machado AR; Fonseca JE
    Ann Rheum Dis; 2021 Feb; 80(2):e22. PubMed ID: 32404340
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli
    Mathian A; Amoura Z
    Ann Rheum Dis; 2021 Feb; 80(2):e26. PubMed ID: 32451345
    [No Abstract]   [Full Text] [Related]  

  • 14. SARS-CoV-2 Infection and COVID-19 in 5 Patients in Ecuador After Prior Treatment with Hydroxychloroquine for Systemic Lupus Erythematosus.
    Zurita MF; Iglesias Arreaga A; Luzuriaga Chavez AA; Zurita L
    Am J Case Rep; 2020 Sep; 21():e927304. PubMed ID: 32978364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.
    Bugatti S; De Stefano L; Bobbio-Pallavicini F; Montecucco C
    RMD Open; 2020 Oct; 6(3):. PubMed ID: 33087414
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.
    Mendel A; Bernatsky S; Askanase A; Bae SC; Clarke AE; Costedoat-Chalumeau N; Gladman DD; Gordon C; Hanly J; Jacobsen S; Kalunian K; Mak A; Mosca M; Pons-Estel BA; Ruiz-Irastorza G; Urowitz M; Vinet É
    Ann Rheum Dis; 2021 Feb; 80(2):1-2. PubMed ID: 32586918
    [No Abstract]   [Full Text] [Related]  

  • 17. Are patients with systemic lupus erythematosus at increased risk for COVID-19?
    Favalli EG; Gerosa M; Murgo A; Caporali R
    Ann Rheum Dis; 2021 Feb; 80(2):e25. PubMed ID: 32451344
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia.
    Espinosa G; Prieto-González S; Llevadot M; Marco-Hernández J; Martínez-Artuña A; Pérez-Isidro A; Rifé E; Cervera R
    Clin Rheumatol; 2021 May; 40(5):2057-2063. PubMed ID: 33677725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to: 'Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus' by Kondo
    Mathian A; Amoura Z
    Ann Rheum Dis; 2021 May; 80(5):e78. PubMed ID: 32759253
    [No Abstract]   [Full Text] [Related]  

  • 20. Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?
    Kabeerdoss J; Danda D
    Int J Rheum Dis; 2020 Aug; 23(8):998-1008. PubMed ID: 32779341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.